Asensus Surgical, Inc.

Equities

ASXC

US04367G1031

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
0.2387 ^USD	-3.20%		-4.14%	-25.15%

Apr. 29	Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program	CI
Apr. 05	North American Morning Briefing : Investors on -2-	DJ

Asensus Surgical, Inc. Announces Impairment Charges for the Fourth Quarter Ended December 31, 2023

March 25, 2024 at 04:45 pm EDT

Asensus Surgical, Inc. announced impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company reported property and equipment impairment of $374,000 against $999,000 a year ago.

Latest news about Asensus Surgical, Inc.

Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program	Apr. 29	CI
North American Morning Briefing : Investors on -2-	Apr. 05	DJ
HC Wainwright Downgrades Asensus Surgical to Neutral From Buy, Adjusts PT to $0.35 From $2	Apr. 04	MT
Sector Update: Health Care Stocks Softer Late Afternoon	Apr. 03	MT
Sector Update: Health Care Stocks Rise Wednesday Afternoon	Apr. 03	MT
Asensus Surgical Shares Soar After KARL STORZ Acquisition Offer Announcement	Apr. 03	MT
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million.	Apr. 02	CI
Asensus Surgical, Inc. announced that it has received $20 million in funding	Apr. 02	CI
Asensus Surgical, Inc. Announces Impairment Charges for the Fourth Quarter Ended December 31, 2023	Mar. 25	CI
Asensus Surgical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Transcript : Asensus Surgical, Inc., Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
Earnings Flash (ASXC) ASENSUS SURGICAL Reports Q4 Revenue $5.4M, vs. Street Est of $5.5M	Mar. 21	MT
Asensus Surgical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21	CI
North American Morning Briefing : Investors -2-	Mar. 21	DJ
Transcript : Asensus Surgical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 12:00 PM	Jan. 11
Asensus Surgical Preliminary Q4 Revenue Tops Estimates; Shares Rise	Jan. 08	MT
Asensus Surgical, Inc. Provides Unaudited Earnings Guidance for the Quarter and Full Year Ending on December 31, 2023	Jan. 08	CI
Asensus Surgical, Inc. Develops the LUNA Surgical System	Jan. 04	CI
Cantor Fitzgerald Downgrades Asensus Surgical to Neutral From Overweight	Nov. 16	MT
Transcript : Asensus Surgical, Inc., Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
Earnings Flash (ASXC) ASENSUS SURGICAL Posts Q3 Revenue $1.1M	Nov. 14	MT
Asensus Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Asensus Surgical Sells Senhance Surgical System to Distribution Partner	Nov. 14	MT
Certain Restricted Stock Units of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023.	23-09-24	CI
Certain Warrants of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023.	23-09-24	CI

Chart Asensus Surgical, Inc.

Duration

Period

More charts

Company Profile

Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Asensus Surgical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.2387 USD

Average target price

0.35 USD

Spread / Average Target

+46.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ASENSUS SURGICAL, INC.	-25.15%	67.07M
ABBOTT LABORATORIES	-3.43%	184B
MEDTRONIC PLC	-1.81%	107B
BECTON, DICKINSON AND COMPANY	-4.15%	67.78B
DEXCOM, INC.	+1.43%	50.66B
CENCORA, INC.	+11.60%	47.64B
HOYA CORPORATION	+4.60%	41.12B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.03%	26.3B
WEST PHARMACEUTICAL SERVICES, INC.	+3.21%	26.04B
TERUMO CORPORATION	+15.06%	25.4B

Other Medical Equipment, Supplies & Distribution